Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1105 to 1110 of 1110 entries
Sorted by: Best Match Show Resources per page
The Effect of Rural Residence on Cancer-Related Self-Efficacy With UK Cancer Survivors Following Treatment.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association

Nelson D, Law GR, McGonagle I, Turner P, Jackson C, Kane R.
PMID: 33289206
J Rural Health. 2020 Dec 02; doi: 10.1111/jrh.12549. Epub 2020 Dec 02.

PURPOSE: To examine rural and urban differences in cancer-related self-efficacy with UK cancer survivors following treatment.METHODS: A cross-sectional postal survey with posttreatment cancer survivors in the East Midlands of England. The survey collected data on demographics and cancer-related self-efficacy...

Cite
Nelson D, Law GR, McGonagle I, et al. The Effect of Rural Residence on Cancer-Related Self-Efficacy With UK Cancer Survivors Following Treatment. J Rural Health. 2020;doi: 10.1111/jrh.12549.
Nelson, D., Law, G. R., McGonagle, I., Turner, P., Jackson, C., & Kane, R. (2020). The Effect of Rural Residence on Cancer-Related Self-Efficacy With UK Cancer Survivors Following Treatment. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association, . https://doi.org/10.1111/jrh.12549
Nelson, David, et al. "The Effect of Rural Residence on Cancer-Related Self-Efficacy With UK Cancer Survivors Following Treatment." The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association vol. (2020). doi: https://doi.org/10.1111/jrh.12549
Nelson D, Law GR, McGonagle I, Turner P, Jackson C, Kane R. The Effect of Rural Residence on Cancer-Related Self-Efficacy With UK Cancer Survivors Following Treatment. J Rural Health. 2020 Dec 02; doi: 10.1111/jrh.12549. Epub 2020 Dec 02. PMID: 33289206.
Copy Download .nbib Format: NLM
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.

Journal of the National Cancer Institute

MacInnis RJ, Knight JA, Chung WK, Milne RL, Whittemore AS, Buchsbaum R, Liao Y, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, Kurian AW, Andrulis IL, John EM, Daly MB, Buys SS, Phillips KA, Hopper JL, Terry MB.
PMID: 33301022
J Natl Cancer Inst. 2021 Jun 01;113(6):785-791. doi: 10.1093/jnci/djaa178.

BACKGROUND: Clinical guidelines often use predicted lifetime risk from birth to define criteria for making decisions regarding breast cancer screening rather than thresholds based on absolute 5-year risk from current age.METHODS: We used the Prospective Family Cohort Study of...

Cite
MacInnis RJ, Knight JA, Chung WK, et al. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort. J Natl Cancer Inst. 2021;113(6):785-791doi: 10.1093/jnci/djaa178.
MacInnis, R. J., Knight, J. A., Chung, W. K., Milne, R. L., Whittemore, A. S., Buchsbaum, R., Liao, Y., Zeinomar, N., Dite, G. S., Southey, M. C., Goldgar, D., Giles, G. G., Kurian, A. W., Andrulis, I. L., John, E. M., Daly, M. B., Buys, S. S., Phillips, K. A., Hopper, J. L., & Terry, M. B. (2021). Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort. Journal of the National Cancer Institute, 113(6), 785-791. https://doi.org/10.1093/jnci/djaa178
MacInnis, Robert J, et al. "Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort." Journal of the National Cancer Institute vol. 113,6 (2021): 785-791. doi: https://doi.org/10.1093/jnci/djaa178
MacInnis RJ, Knight JA, Chung WK, Milne RL, Whittemore AS, Buchsbaum R, Liao Y, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, Kurian AW, Andrulis IL, John EM, Daly MB, Buys SS, Phillips KA, Hopper JL, Terry MB. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort. J Natl Cancer Inst. 2021 Jun 01;113(6):785-791. doi: 10.1093/jnci/djaa178. PMID: 33301022; PMCID: PMC8168075.
Copy Download .nbib Format: NLM
Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model.

Journal of peptide science : an official publication of the European Peptide Society

Graham GV, Conlon JM, Moffett RC, Abdel-Wahab YH, Flatt PR.
PMID: 33843129
J Pept Sci. 2021 Aug;27(8):e3328. doi: 10.1002/psc.3328. Epub 2021 Apr 11.

The abilities of the long-acting, dual-agonist anti-diabetic peptides [D-Ala

Cite
Graham GV, Conlon JM, Moffett RC, et al. Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model. J Pept Sci. 2021;27(8):e3328doi: 10.1002/psc.3328.
Graham, G. V., Conlon, J. M., Moffett, R. C., Abdel-Wahab, Y. H., & Flatt, P. R. (2021). Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model. Journal of peptide science : an official publication of the European Peptide Society, 27(8), e3328. https://doi.org/10.1002/psc.3328
Graham, Galyna V, et al. "Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model." Journal of peptide science : an official publication of the European Peptide Society vol. 27,8 (2021): e3328. doi: https://doi.org/10.1002/psc.3328
Graham GV, Conlon JM, Moffett RC, Abdel-Wahab YH, Flatt PR. Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model. J Pept Sci. 2021 Aug;27(8):e3328. doi: 10.1002/psc.3328. Epub 2021 Apr 11. PMID: 33843129.
Copy Download .nbib Format: NLM
Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial.

The Lancet. Healthy longevity

Walsh JS, Jacques RM, Schomburg L, Hill TR, Mathers JC, Williams GR, Eastell R.
PMID: 33842907
Lancet Healthy Longev. 2021 Apr;2(4):e212-e221. doi: 10.1016/S2666-7568(21)00051-9.

BACKGROUND: Observational and preclinical studies show associations between selenium status, bone health, and physical function. Most adults in Europe have serum selenium below the optimum range. We hypothesised that selenium supplementation could reduce pro-resorptive actions of reactive oxygen species...

Cite
Walsh JS, Jacques RM, Schomburg L, et al. Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial. Lancet Healthy Longev. 2021;2(4):e212-e221doi: 10.1016/S2666-7568(21)00051-9.
Walsh, J. S., Jacques, R. M., Schomburg, L., Hill, T. R., Mathers, J. C., Williams, G. R., & Eastell, R. (2021). Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial. The Lancet. Healthy longevity, 2(4), e212-e221. https://doi.org/10.1016/S2666-7568(21)00051-9
Walsh, Jennifer S, et al. "Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial." The Lancet. Healthy longevity vol. 2,4 (2021): e212-e221. doi: https://doi.org/10.1016/S2666-7568(21)00051-9
Walsh JS, Jacques RM, Schomburg L, Hill TR, Mathers JC, Williams GR, Eastell R. Effect of selenium supplementation on musculoskeletal health in older women: a randomised, double-blind, placebo-controlled trial. Lancet Healthy Longev. 2021 Apr;2(4):e212-e221. doi: 10.1016/S2666-7568(21)00051-9. PMID: 33842907; PMCID: PMC8020713.
Copy Download .nbib Format: NLM
Declining interest in clinical imaging during the COVID-19 pandemic: An analysis of Google Trends data.

Clinical imaging

Adelhoefer S, Henry TS, Blankstein R, Graham G, Blaha MJ, Dzaye O.
PMID: 33260013
Clin Imaging. 2021 May;73:20-22. doi: 10.1016/j.clinimag.2020.11.037. Epub 2020 Nov 25.

OBJECTIVE: Current evidence suggests a decrease in elective diagnostic imaging procedures during the COVID-19 pandemic with potentially severe long-term consequences. The aim of this study was to quantify recent trends in public interest and related online search behavior for...

Cite
Adelhoefer S, Henry TS, Blankstein R, et al. Declining interest in clinical imaging during the COVID-19 pandemic: An analysis of Google Trends data. Clin Imaging. 2020;73:20-22doi: 10.1016/j.clinimag.2020.11.037.
Adelhoefer, S., Henry, T. S., Blankstein, R., Graham, G., Blaha, M. J., & Dzaye, O. (2021). Declining interest in clinical imaging during the COVID-19 pandemic: An analysis of Google Trends data. Clinical imaging, 7320-22. https://doi.org/10.1016/j.clinimag.2020.11.037
Adelhoefer, Siegfried, et al. "Declining interest in clinical imaging during the COVID-19 pandemic: An analysis of Google Trends data." Clinical imaging vol. 73 (2021): 20-22. doi: https://doi.org/10.1016/j.clinimag.2020.11.037
Adelhoefer S, Henry TS, Blankstein R, Graham G, Blaha MJ, Dzaye O. Declining interest in clinical imaging during the COVID-19 pandemic: An analysis of Google Trends data. Clin Imaging. 2021 May;73:20-22. doi: 10.1016/j.clinimag.2020.11.037. Epub 2020 Nov 25. PMID: 33260013.
Copy Download .nbib Format: NLM
Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

The Cochrane database of systematic reviews

Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R.
PMID: 34891214
Cochrane Database Syst Rev. 2021 Dec 10;12:CD010173. doi: 10.1002/14651858.CD010173.pub3.

BACKGROUND: The early detection of oral cavity squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD), followed by appropriate treatment, may improve survival and reduce the risk for malignant transformation respectively. This is an update of a Cochrane...

Cite
Walsh T, Warnakulasuriya S, Lingen MW, et al. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021;12:CD010173doi: 10.1002/14651858.CD010173.pub3.
Walsh, T., Warnakulasuriya, S., Lingen, M. W., Kerr, A. R., Ogden, G. R., Glenny, A. M., & Macey, R. (2021). Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. The Cochrane database of systematic reviews, 12CD010173. https://doi.org/10.1002/14651858.CD010173.pub3
Walsh, Tanya, et al. "Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults." The Cochrane database of systematic reviews vol. 12 (2021): CD010173. doi: https://doi.org/10.1002/14651858.CD010173.pub3
Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2021 Dec 10;12:CD010173. doi: 10.1002/14651858.CD010173.pub3. PMID: 34891214; PMCID: PMC8664456.
Copy Download .nbib Format: NLM
Showing 1105 to 1110 of 1110 entries